CONMED Corp false 0000816956 0000816956 2024-09-30 2024-09-30

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 30, 2024

 

 

CONMED CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39218   16-0977505

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

 

11311 Concept Blvd

Largo, FL

   33773
(Address of principal executive offices)   (Zip code)

(727) 392-6464

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (See General Instruction A.2 below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Rule 12(b) of the Act

 

Title of each class

  

Trading

Symbol

  

Name of each exchange

on which registered

Common Stock, $0.01 par value   CNMD   NYSE

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 7.01

Financial Regulation FD Disclosure.

On September 30, 2024, CONMED Corporation (the “Company”) issued the following statement on the impact from Hurricane Helene on the Company’s operations:

The path of Hurricane Helene impacted the Company’s manufacturing facility in Largo, Florida and the Company’s distribution center in Lithia Springs, Georgia. The Company prioritizes the safety of its employees, and ceased manufacturing operations at its Largo, Florida facility for approximately 24 hours. Employee absences at the Largo facility were significant after the storm had passed, temporarily impacting the facility’s manufacturing. As of September 30, 2024, the Company has confirmed that all employees are safe, and no significant damage was reported at either facility, and both facilities are back to normal operations.

The Company also understands that its customers in the southeastern United States delayed surgeries and other activity due to the storm, and some areas continue to be affected. The Company is unable to estimate the financial impact of Hurricane Helene at this time.

The information contained in this Item 7.01 is being “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). The information in this Item 7.01 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act or into any filing or other document pursuant to the Exchange Act, except as otherwise expressly stated in any such filing.

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: September 30, 2024     CONMED CORPORATION
      (Registrant)
    By:  

/s/ Todd W. Garner

    Name:   Todd W. Garner
    Title:   Executive Vice President-Chief Financial Officer
v3.24.3
Document and Entity Information
Sep. 30, 2024
Cover [Abstract]  
Entity Registrant Name CONMED Corp
Amendment Flag false
Entity Central Index Key 0000816956
Document Type 8-K
Document Period End Date Sep. 30, 2024
Entity Incorporation State Country Code DE
Entity File Number 001-39218
Entity Tax Identification Number 16-0977505
Entity Address, Address Line One 11311 Concept Blvd
Entity Address, City or Town Largo
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33773
City Area Code (727)
Local Phone Number 392-6464
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.01 par value
Trading Symbol CNMD
Security Exchange Name NYSE
Entity Emerging Growth Company false
CONMED (NYSE:CNMD)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more CONMED Charts.
CONMED (NYSE:CNMD)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more CONMED Charts.